What are ResMed's total assets?

ResMed (RMD) holds $8.8B in total assets, up 16.1% year over year.

How much debt does ResMed have?

ResMed carries $1.1B in total debt against $6.5B of shareholders' equity, a debt-to-equity ratio of 0.17.

How much cash does ResMed have?

ResMed holds $1.7B in cash and equivalents.

Can ResMed cover its short-term obligations?

Its current ratio is 3.01 — current assets exceed current liabilities.

Where does ResMed's balance sheet data come from?

Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ResMed RMD Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$1.21B+407%	$238.36M+4.6%	$227.89M-16.7%	$273.71M-7.3%
Accounts receivable, net	$939.49M+12.2%	$837.28M+18.8%	$704.91M+22.4%	$575.95M-6.2%
Inventories	$927.71M+12.8%	$822.25M-17.6%	$998.01M+34.2%	$743.91M+62.8%
Raw materials	$367.28M+3.3%	$355.57M-22.6%	$459.13M+29.2%	$355.23M+129%
Work in process	$2.55M-6.0%	$2.71M-31.4%	$3.96M+28.6%	$3.08M-33.8%
Finished goods	$557.88M+20.2%	$463.97M-13.3%	$534.93M+38.7%	$385.61M+29.8%
Prepaid expenses and other current assets	$428.95M-6.7%	$459.83M+5.2%	$437.02M+29.3%	$337.91M+62.3%
Income taxes receivable	$165.03M+53.3%	$107.62M-5.6%	$114.01M+14.8%	$99.35M+37.2%
Contract assets	$51.18M—	——	——	——
Derivative assets	$6.81M+180%	$2.43M+1.1%	$2.41M+1,403%	$160K—
Total current assets	$3.51B+48.7%	$2.36B-0.4%	$2.37B+22.6%	$1.93B+22.7%
Property and equipment, net	$550.79M+0.5%	$548.03M+1.9%	$537.86M+8.0%	$498.18M+7.5%
Accumulated depreciation	$705.31M-3.0%	$726.97M+8.8%	$668.01M+5.5%	$633.11M+1.8%
Operating lease right-of-use assets	$167.5M+10.8%	$151.12M+18.1%	$127.96M-3.3%	$132.31M+2.9%
Goodwill	$3.05B+7.2%	$2.84B+2.6%	$2.77B+43.1%	$1.94B+0.4%
Intangible assets, net	$464.86M-4.3%	$485.9M-12.0%	$552.34M+59.7%	$345.94M-11.9%
Other non-current assets	$253.12M+24.3%	$203.57M+53.1%	$132.97M+66.7%	$79.75M-0.2%
Equity method investments	$63.64M-13.7%	$73.74M+7.3%	$68.75M+75.0%	$39.29M+70.8%
Total noncurrent assets	$4.67B+3.4%	$4.51B+3.0%	$4.38B+38.5%	$3.16B+0.3%
Total assets	$8.17B+18.9%	$6.87B+1.8%	$6.75B+32.5%	$5.1B+7.8%
Accounts payable	$278.16M+17.0%	$237.73M+57.7%	$150.76M-5.3%	$159.25M+15.4%
Accrued expenses	$402.25M+6.5%	$377.68M+3.3%	$365.66M+6.1%	$344.72M+7.5%
Deferred revenue	$166.03M+8.8%	$152.55M+10.5%	$138.07M+27.1%	$108.67M-0.9%
Current portion of long-term debt	$9.9M0.0%	$9.9M0.0%	$9.9M-0.1%	$9.92M-17.4%
Operating lease liabilities, current	$30.51M+20.7%	$25.28M+15.3%	$21.92M+0.3%	$21.86M-7.3%
Short-term borrowings	$9.9M0.0%	$9.9M0.0%	$9.9M-0.1%	$9.92M-17.4%
Contract liabilities	$156.8M+14.2%	$137.34M+15.2%	$119.19M+24.9%	$95.46M+4.3%
Income taxes payable	$132.27M+23.0%	$107.52M+48.9%	$72.22M+60.9%	$44.89M+69.1%
Total current liabilities	$1.02B+11.9%	$910.66M+20.1%	$758.53M+10.0%	$689.3M-24.4%
Long-term debt	$668.29M-5.5%	$707.21M-50.9%	$1.44B+85.9%	$775.24M+18.3%
Operating lease liabilities, non-current	$153.02M+8.2%	$141.44M+21.0%	$116.85M-3.0%	$120.45M+4.9%
Other non-current liabilities	$141.52M+235%	$42.26M-38.0%	$68.17M+1,041%	$5.97M-12.2%
Total noncurrent liabilities	$1.19B+8.2%	$1.1B-41.1%	$1.86B+78.2%	$1.05B+12.4%
Total liabilities	$2.21B+9.9%	$2.01B-23.4%	$2.62B+51.1%	$1.74B-5.8%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	$761K+29.4%	$588K0.0%	$588K+0.3%	$586K+0.5%
Additional paid-in capital	$2.03B+7.2%	$1.9B+7.0%	$1.77B+5.3%	$1.68B+3.7%
Retained earnings	$6.08B+21.8%	$4.99B+17.4%	$4.25B+17.7%	$3.61B+17.3%
Accumulated other comprehensive income (loss)	-$74.7M+70.3%	-$251.53M+7.7%	-$272.53M+12.9%	-$312.75M-61.6%
Treasury stock	$2.07B+16.9%	$1.77B+9.2%	$1.62B0.0%	$1.62B0.0%
Total stockholders' equity	$5.97B+22.7%	$4.86B+17.8%	$4.13B+22.9%	$3.36B+16.5%
Total liabilities and stockholders' equity	$8.17B+18.9%	$6.87B+1.8%	$6.75B+32.5%	$5.1B+7.8%
Allowance for Doubtful Accounts	$22.42M+6.1%	$21.13M-10.5%	$23.6M+1.5%	$23.26M-27.6%
Allowance for Doubtful Accounts Receivable (Current)	$22.42M+6.1%	$21.13M-10.5%	$23.6M+1.5%	$23.26M-27.6%
Finished goods	$557.88M+20.2%	$463.97M-13.3%	$534.93M+38.7%	$385.61M+29.8%
Other current assets	$164.5M-8.6%	$180.01M0.0%	$179.93M+37.1%	$131.27M—
Deferred Finance Costs, Current	$100K0.0%	$100K+2.0%	$98K+16.7%	$84K—
Trading Securities in Marketable Securities	$63.64M-13.7%	$73.74M+7.3%	$68.75M+75.0%	$39.29M+70.8%
Deferred Tax Assets and Other Non-Current Assets	$253.12M+24.3%	$203.57M+53.1%	$132.97M+66.7%	$79.75M+1,463%
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments	$63.64M-13.7%	$73.74M+7.3%	$68.75M+75.0%	$39.29M+70.8%
Investments - Amortized Cost Basis	$63.64M-13.7%	$73.74M+7.3%	$68.75M+75.0%	$39.29M+70.8%
Intangible assets — net	$464.86M-4.3%	$485.9M-12.0%	$552.34M+59.7%	$345.94M-11.9%
Operating lease right-of-use assets	$167.5M+10.8%	$151.12M+18.1%	$127.96M-3.3%	$132.31M+2.9%
Other non-current assets	$185.84M-34.6%	$284M+8.2%	$262.45M+52.8%	$171.75M+6.7%
Property, plant and equipment at cost	$1.26B-1.5%	$1.27B+5.7%	$1.21B+6.6%	$1.13B+4.2%
Operating Lease Right-of-Use Assets in Other Assets	$167.5M+10.8%	$151.12M+18.1%	$127.96M-3.3%	$132.31M+2.9%
Software and Technology Licenses, Net	$185.84M-34.6%	$284M+8.2%	$262.45M+52.8%	$171.75M+6.7%
Accrued Contingent Liabilities	$700K-12.5%	$800K-97.5%	$32.6M+34.7%	$24.2M—
Accrued Progress Collections and Price Adjustments	$156.8M+14.2%	$137.34M+15.2%	$119.19M+24.9%	$95.46M+4.3%
Other Commercial Liabilities	$402.25M+6.5%	$377.68M+3.3%	$365.66M+6.1%	$344.72M+7.5%
Accrued Income Taxes, Current	$132.27M+23.0%	$107.52M+48.9%	$72.22M+60.9%	$44.89M-85.4%
Accrued Liabilities, Current	$402.25M+6.5%	$377.68M+3.3%	$365.66M+6.1%	$344.72M+7.5%
Derivative Liabilities - Fair Value	$132.82M+264%	$36.54M-48.3%	$70.7M+3,531%	$1.95M—
Restructuring Reserve	——	——	——	——
Contract Liabilities, Non-Current	$156.8M+14.2%	$137.34M+15.2%	$119.19M+24.9%	$95.46M+4.3%
Deferred revenue, net of current portion	$156.8M+14.2%	$137.34M+15.2%	$119.19M+24.9%	$95.46M+4.3%
Total Carrying Value of Debt	$660M-5.7%	$700M-51.2%	$1.44B+86.4%	$770M+19.2%
Unrecognized Tax Benefits	$77.68M-2.1%	$79.34M-12.5%	$90.65M+833%	$9.71M-14.2%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	190.3M+0.4%	189.6M+0.4%	188.9M+0.3%	188.2M+0.4%
Convertible Preferred Stock Authorized Shares	2M0.0%	2M0.0%	2M0.0%	2M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Additional paid-in capital	$2.03B+7.2%	$1.9B+7.0%	$1.77B+5.3%	$1.68B+3.7%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Cumulative Cost Basis	$1.26B-1.5%	$1.27B+5.7%	$1.21B+6.6%	$1.13B+4.2%
Gross Assets/Liabilities	$132.82M+264%	$36.54M-48.3%	$70.7M+3,531%	$1.95M—
Allowance for doubtful accounts	$22.42M+6.1%	$21.13M-10.5%	$23.6M+1.5%	$23.26M-27.6%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$350M0.0%	$350M0.0%	$350M0.0%	$350M0.0%
Common stock, shares issued (in shares)	$190.31M+0.4%	$189.57M+0.4%	$188.9M+0.3%	$188.25M+0.4%
Common Stock, Shares, Outstanding	$146.39M-0.4%	$146.9M-0.1%	$147.06M+0.4%	$146.41M+0.5%
Long-term debt, gross	$660M-5.7%	$700M-51.2%	$1.44B+86.4%	$770M+19.2%
Deferred Finance Costs Noncurrent Net	$1.61M-40.2%	$2.69M-28.7%	$3.77M-19.4%	$4.68M+76.5%
Deferred Income Taxes and Other Tax Liabilities, Noncurrent	$77.68M-2.1%	$79.34M-12.5%	$90.65M+833%	$9.71M-14.2%
Derivative Liability	$132.82M+264%	$36.54M-48.3%	$70.7M+3,531%	$1.95M—
Equity Investments	$152.9M+1.1%	$151.23M+3.2%	$146.54M+151%	$58.38M-15.7%
Equity Investments, Total by Measurement Category	$152.9M+1.1%	$151.23M+3.2%	$146.54M+151%	$58.38M-15.7%
Equity method investments (Note 11)	$76.18M+16.4%	$65.46M+0.1%	$65.37M+559%	$9.92M-42.2%
Trading securities, cost	$63.64M-13.7%	$73.74M+7.3%	$68.75M+75.0%	$39.29M+70.8%
Loss Contingency Accrual	$700K-12.5%	$800K—	——	——
Loss Contingency Estimate Of Possible Loss	$34.1M-4.7%	$35.8M+9.8%	$32.6M+34.7%	$24.2M—
Fair value	$13.08M+8.8%	$12.03M-3.2%	$12.42M+35.5%	$9.17M-68.5%
Number of patents	——	——	——	7—
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Prepaid inventories	$48.25M-72.0%	$172.2M+20.3%	$143.08M+33.4%	$107.29M—
Restructuring Reserve	——	——	——	——
Short-term debt	$10M0.0%	$10M0.0%	$10M0.0%	$10M—
Treasury stock, shares (in shares)	$43.93M+3.0%	$42.66M+2.0%	$41.84M0.0%	$41.84M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ResMed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are ResMed's total assets?: ResMed (RMD) holds $8.8B in total assets, up 16.1% year over year.
How much debt does ResMed have?: ResMed carries $1.1B in total debt against $6.5B of shareholders' equity, a debt-to-equity ratio of 0.17.
How much cash does ResMed have?: ResMed holds $1.7B in cash and equivalents.
Can ResMed cover its short-term obligations?: Its current ratio is 3.01 — current assets exceed current liabilities.
Where does ResMed's balance sheet data come from?: Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.